dr. soliman on impact of mammaprint in patients with early-stage breast cancer
Published 7 years ago • 633 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
0:58
dr. soliman on investigational combination therapies in patients with breast cancer
-
2:02
dr. soliman the utility of adcs in breast cancer
-
1:03:44
new & supporting data for optimizing therapy in her2 breast cancer | dr. meisel & dr. soliman
-
29:58
genomic profiling in early stage breast cancer & role of mammaprint & blueprint testing | oncquest
-
7:07
2021 asco direct jacksonville | early stage breast cancer summary | dr. hatem soliman
-
0:47
dr. shulman on chemotherapy in adjuvant breast cancer
-
1:23
brock schroeder discusses bci findings in er breast cancer
-
1:50
dr. soliman: do you have a go-to regimen for patients with er /pr /her2-negative disease?
-
1:12
dr. soliman on the rationale for using immunotherapy in tnbc
-
1:59
dr. melisko reflects on findings from the mindact trial in breast cancer
-
7:04
treatment for early-stage er breast cancer
-
1:09
dr. piccart on the mindact study for early-stage breast cancer
-
6:41
practice-changing results from the mindact trial
-
6:49
martin dietrich, md | fl cancer specialists | asco20 breast cancer reactions: mindact for earlystage
-
1:17
dr. albain on the 21- and 70-gene assays in breast cancer
-
3:56
using mammaprint to select patients who may not need adjuvant chemotherapy – the results of mindact
-
9:51
mindact trial design and results in breast cancer
-
4:48
oncotype dx testing and the tailorx trial
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer